Please login to the form below

Not currently logged in
Email:
Password:

Huntsworth appoints new CEO

Huntsworth Health has appointed Neil Matheson to the role of chief executive officer

Huntsworth Health has appointed Neil Matheson to the role of chief executive officer. Matheson was formerly chief executive of the company's North American operations; in his new role, he will lead the company's global operations. Sandy Royden continues as CEO of Huntsworth Health Europe.

Matheson's appointment follows the resignation of David Rowley who was CEO for eight years. Huntsworth Plc, acquired the company that Rowley founded, PBC, in 2001, providing the platform upon which Huntsworth Health was built. Rowley's leadership contributed significantly to the growth of the company, which employs more than 400 people worldwide and has amassed £50m in revenue.

Lord Chadlington, Chief Executive of Huntsworth Plc, said: "I am confident that Neil will build energetically on the Huntsworth Health platform… and lead us forward to the next stage in our global development." 

Matheson said: "I look forward to this opportunity to grow the Huntsworth Health family of best-in-class agency brands on a global scale. We have a fantastic executive team leading our brands and the talent within those brands is unparalleled."

"Sandy Royden and her talented team at Huntsworth Health Europe have done a fantastic job of building the business into a formidable force in European healthcare communications and I know they will continue to grow the European business as a critical part of our global family," added Matheson.

Huntsworth Health has offices in Philadelphia, New York, San Francisco, and London and has access to 71 offices in 30 countries through the Huntsworth plc global network.

7th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics